These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5517863)

  • 1. [Interruption of pregnancy in isoimmunized women].
    Marcushamer B; Sentíes L; Santos J; Ortiz de la Peña R; Abarca García J
    Ginecol Obstet Mex; 1970 Jul; 28(165):37-48. PubMed ID: 5517863
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood copper content in isoimmunized pregnant women, women in labor, and in their newborn].
    Levkovich KK; Sadykov BG
    Vopr Okhr Materin Det; 1971 Jan; 16(1):48-51. PubMed ID: 5575088
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of citroflavonoids in the prevention of complications due to fetomaternal blood incompatibility].
    Garès R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):288-90. PubMed ID: 5962895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Surveillance of Rh negative pregnant women by the family physician].
    García Padilla A; Posada Urios F
    Ginecol Obstet Mex; 1970 Jul; 28(165):49-57. PubMed ID: 5517864
    [No Abstract]   [Full Text] [Related]  

  • 5. [On premature induction of labor in immunization of the organism of the pregnant woman].
    Grishchenko II; Shileĭko VA
    Akush Ginekol (Mosk); 1966 Apr; 42(4):53-8. PubMed ID: 5987805
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis in Rh immunized pregnant women.
    Simonovits I; Vedrödi K; Jókuti I; Forgács J; Gy S
    Acta Haematol Pol; 1981; 12(2):65-7. PubMed ID: 6795880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic use of immunodepressive agents in materno-fetal isoimmunization].
    Brigato G; Ilacqua N; Marigo A; Fantucci D; Palazzi G
    Minerva Ginecol; 1975 Mar; 27(3):185-7. PubMed ID: 1128835
    [No Abstract]   [Full Text] [Related]  

  • 8. [3 cases of transfusion of the fetus "in utero" for severe feto-maternal blood incompatibility].
    Grosieux P; Barraya PL; Leroux JP; Aubert F; Rouchy R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(3):350-4. PubMed ID: 5479067
    [No Abstract]   [Full Text] [Related]  

  • 9. Future trends in antepartum assessment of the Rh problem.
    Queenan JT
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):469-72. PubMed ID: 5001768
    [No Abstract]   [Full Text] [Related]  

  • 10. [Consideration of 116 pregnancies with feto-maternal immunization. (Maternité de Pellegrin, 19571964)].
    Mahon R; Pery G; Soumireu-Mourat J; Van Oort JL
    Rev Fr Gynecol Obstet; 1966 Oct; 61(10):685-700. PubMed ID: 5983668
    [No Abstract]   [Full Text] [Related]  

  • 11. Modern obstetric management of the Rh problem.
    Douglas RG; Queenan JT
    N C Med J; 1966 Nov; 27(11):521-7. PubMed ID: 5232145
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 13. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of isoimmunized women in order to prevent hemolytic disease of the newborn].
    Grishchenko II; Shileĭko VA
    Akush Ginekol (Mosk); 1971 Aug; 47(8):8-13. PubMed ID: 4117023
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-D isoimmunization: cases at the L. Mangiagalli Obstetrical and Gynecological Clinic I from June 1974 to December 1978. Perinatal results].
    Brambati B; Zuliani G; Regalia AL; Pardi G; Chierichetti G; Dambrosio F; Caccamo ML
    Ann Ostet Ginecol Med Perinat; 1980; 101(4):225-34. PubMed ID: 6787970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary clinical experiences with immunosuppressive agents in prenatal treatment of Rh isoimmunization].
    Viozzi A; Gasparini G; Cagliari P
    Minerva Ginecol; 1970 May; 22(9):462-3. PubMed ID: 4995416
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood group immunization during pregnancy in Netherlands].
    Heringa MP; Waelput AJ; Flikweert S
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):454-5. PubMed ID: 10719560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent considerations on the Rh factor in obstetric practice].
    Gagnon MG
    Union Med Can; 1966 Dec; 95(12):1408-12. PubMed ID: 5996222
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of the administration of citrobioflavonoids and vitamin C on antibody titers in Rh-negative isoimmunized pregnant women].
    Morganti G; Gualandri V; Cozzi M; Gianotti G; Vierucci A
    Riv Emoter Immunoematol; 1965; 12(1):19-27. PubMed ID: 4958752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.